Literature DB >> 14501946

The genetic background of hypertensive, septic rats determines outcome improvement with antibiotic and G-CSF prophylaxis.

Artur Bauhofer1, Bjirn Tischer, Martin Middeke, Ulrike Plaul, Wilfried Lorenz, Alexander Torossian.   

Abstract

Hypertension is proposed as a risk factor among others (high age, diabetes mellitus, and pre- and intraoperative bleeding) for adverse outcomes, such as severe infections, leading to sepsis and to multiple organ failure as the most deleterious complication. Hypertension was modeled with spontaneous hypertensive rats (SHR) and Dahl salt-sensitive (DS) rats and the infective complication by polymicrobial, peritoneal contamination, and infection (PCI). The concept of clinic modeling randomized trials was used to simulate clinical complexity, including a relevant antibiotic prophylaxis in combination with granulocyte-colony stimulating factor (G-CSF) and clinical trial conditions. Outcome parameters were: survival, systemic cytokines (protein), and organ-specific cytokine levels (mRNA). With low complexity (no prophylaxis), 28% of the animals in the Wistar and 50% in the SHR group survived (P=0.17). Tumor necrosis factor-alpha levels were lower in the liver of SHR vs. Wistar rats with PCI (P<0.01). The anti-inflammatory cytokine interleukin (IL)-10 was expressed on a higher level in SHR with PCI compared with Wistar rats (P<0.01). With increased complexity (antibiotic and G-CSF prophylaxis) the survival rate was increased from 50% in Wistar rats to 89% in SHR (P<0.01) and the mRNA expression of IL-6 was decreased in the kidney of SHR (P<0.05). Survival rate was 44% in the DS rats vs. 67% of the Wistar rats (P=0.18). The mRNA expression of tumor necrosis factor-alpha and IL-10 was reduced (P<0.01) by pretreatment in the liver of DS rats with PCI. The hypertensive, genetically distinct SHR and DS rats express different patterns of pro- and anti-inflammatory cytokine levels after PCI. G-CSF and antibiotic prophylaxis increases only in SHR survival and decreases IL-6 mRNA expression in the kidney significantly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14501946     DOI: 10.1097/01.shk.0000084342.58020.1e

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  The influence of G-CSF addition to antibiotic treatment of experimental sepsis on pulmonary tissue.

Authors:  Sevim Aydin; Rahmet Caylan; Kemalettin Aydin; Esin Yulug; Engin Yenilmez; Iftihar Koksal
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

Review 2.  Hypotension as a marker or mediator of perioperative organ injury: a narrative review.

Authors:  Gareth L Ackland; Tom E F Abbott
Journal:  Br J Anaesth       Date:  2022-02-09       Impact factor: 11.719

3.  Dependence of positive effects of granulocyte colony-stimulating factor on the antibiotic regimen: evaluation in rats with polymicrobial peritonitis.

Authors:  Artur Bauhofer; Alexander Torossian; Wilfried Lorenz; Martin Middeke; Ulrike Plaul; Philipp Schütz; Benno Stinner; Markus Hattel; Ilhan Celik
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

4.  Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.

Authors:  Zuzana Stozicka; Norbert Zilka; Petr Novak; Branislav Kovacech; Ondrej Bugos; Michal Novak
Journal:  J Neuroinflammation       Date:  2010-10-12       Impact factor: 8.322

5.  Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy.

Authors:  Tomas Smolek; Veronika Cubinkova; Veronika Brezovakova; Bernadeta Valachova; Peter Szalay; Norbert Zilka; Santosh Jadhav
Journal:  Front Aging Neurosci       Date:  2019-12-11       Impact factor: 5.750

6.  Differential effects of antibiotics in combination with G-CSF on survival and polymorphonuclear granulocyte cell functions in septic rats.

Authors:  Artur Bauhofer; Markus Huttel; Wilfried Lorenz; Daniel I Sessler; Alexander Torossian
Journal:  BMC Infect Dis       Date:  2008-04-30       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.